Herborium's sexual health product poised to enter $1 billion U.S. market with feauture in USA Today's Sexual Health magazine

Herborium's sexual health product poised to enter $1 billion U.S. market with
                feauture in USA Today's Sexual Health magazine

PR Newswire

FORT LEE, N.J., Oct. 16, 2012

FORT LEE, N.J., Oct. 16, 2012 /PRNewswire/ -- Herborium Group, Inc., (HBRM)
www.herborium.com, a Botanical Therapeutics® Company announced today that its
Sexual Products Lasting Pleasure® and Lasting Power® that representover $1
billionmarket potential will be featured in upcoming USA Today Sexual Health
Magazineon 28, 29 and30 of October 2012 with over 3 Million readers expected
to preview the publicationfrom New York to Los Angeles. In addition, Dr.
Agnes P. Olszewski , CEOand Chairwomen of Herborium Group will provide an
Editorial for the publication. The publication will also be provided to
distributors, retailers and experts at the first Sex Summit Conference in San
Francisco on October 27th.

Herborium proprietary all natural sexual health products will debut onthe
market in November 2012. A new digital media campaign is to be launched on
October 28^th and will be associated with the Kamasutra™ Spirit marketing
strategy. Each bottle of Kamasutra™ and related digital and traditional
marketing and sales materials include reference and leads to Herborium
products. Herborium Sexual Health Therapeutics are also a subject of market
and industry promotion by SSPR (top 20 Public Relations firm in the USA).
Products are expected to start generating revenues in the 4^th Quarter of 2012
and will also gain the distribution support form Kamasutra sales force.

Herborium received a number of inquiries for distribution arrangements of the
products and for private label arrangements, and expects both products to add
substantially to the Company's bottom line in 2013. 

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on
developing, licensing, and marketing proprietary, botanical based medicinal
products to consumers and healthcare professionals. The Company uses clinical
validation to establish and maintain a differential advantage. The company
sells its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com. Soon: www.herboriumsh.com.

One of our most important responsibilities is to communicate with shareholders
in an open and direct manner. Comments are based on current management
expectations, and are considered "forward-looking statements," generally
preceded by words such as "plans," "expects," "believes," "anticipates," or
"intends." We cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or alter
forward-looking statements as the result of new information or future events.
The Company urges investors to review the risks and uncertainties contained
within its filings with the OTC Markets and/or Securities and Exchange

For more information please inquire: Investorsrelations@herborium.com

SOURCE Herborium Group, Inc.

Website: http://www.herborium.com
Press spacebar to pause and continue. Press esc to stop.